| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0735-1097(10)80347-X |
| P698 | PubMed publication ID | 2212376 |
| P2093 | author name string | J Dusleag | |
| B Eber | |||
| N S Khurmi | |||
| W W Klein | |||
| P2860 | cites work | The variable effects of angiotensin converting enzyme inhibition on myocardial ischaemia in chronic stable angina | Q34000264 |
| Selection of optimal drug therapy for the patient with angina pectoris | Q39379156 | ||
| Angiotensin converting enzyme inhibitors and ischaemic heart disease | Q39526053 | ||
| Angiotensin converting enzyme inhibitors. II. Clinical use. | Q39543716 | ||
| Exercise stress testing in evaluation of patients with ischemic heart disease | Q39980979 | ||
| Rational medical therapy for stable angina pectoris | Q41433744 | ||
| Recent advances in knowledge about beta-adrenergic receptors: application to clinical cardiology | Q41452822 | ||
| A comparison of nine calcium ion antagonists and propranolol: exercise tolerance, heart rate and ST-segment changes in patients with chronic stable angina pectoris | Q42219545 | ||
| Exacerbation of vasotonic angina pectoris by propranolol | Q42257868 | ||
| Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications | Q44729426 | ||
| Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor | Q47274480 | ||
| A multicenter study of the safety and efficacy of benazepril hydrochloride, a long-acting angiotensin-converting enzyme inhibitor, in patients with chronic congestive heart failure. | Q54359329 | ||
| The effect of angiotensin converting enzyme inhibition on coronary blood flow and hemodynamics in patients without coronary artery disease | Q54526537 | ||
| Randomized double-blind comparison of metoprolol, nifedipine, and their combination in chronic stable angina: effects on total ischemic activity and heart rate at onset of ischemia | Q67944893 | ||
| Comparison of different methods of ST measurement for evaluation of myocardial ischaemia in Holter monitoring | Q68067479 | ||
| Angina pectoris: pathophysiology, evaluation, and treatment | Q68755129 | ||
| Reproducibility and validity of ambulatory ST segment monitoring in patients with chronic stable angina pectoris | Q69008680 | ||
| Effect of diltiazem and propranolol on myocardial ischaemia during unrestricted daily life in patients with effort-induced chronic stable angina pectoris | Q69212719 | ||
| Effects of titrated beta blockade (metoprolol) on silent myocardial ischemia in ambulatory patients with coronary artery disease | Q69258669 | ||
| Suppression of silent ischemia by metoprolol without alteration of morning increase of platelet aggregability in patients with stable coronary artery disease | Q69485574 | ||
| Effect of propranolol on indices of intermittent myocardial ischemia, assessed by exercise testing and ambulatory ST-segment monitoring | Q69567038 | ||
| Crossover design for the dose determination of an angiotensin converting enzyme inhibitor in hypertension | Q69571829 | ||
| Ergometric evaluation of the effects of enalapril maleate in normotensive patients with stable angina | Q69825820 | ||
| Lack of reflex increase in myocardial sympathetic tone after captopril: potential antianginal effect | Q69880735 | ||
| Preservation of ischemic myocardium by a new converting enzyme inhibitor, enalaprilic acid, in acute myocardial infarction | Q70077425 | ||
| Acute effects of captopril on the coronary circulation of patients with hypertension and angina | Q70216493 | ||
| Reproducibility of multistage graded exercise testing in patients with chronic stable angina | Q70589157 | ||
| A new rationale for the clinical approach to the patient with angina pectoris | Q70930998 | ||
| Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris | Q72419695 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | benazepril | Q592802 |
| myocardial ischemia | Q6947906 | ||
| P304 | page(s) | 948-956 | |
| P577 | publication date | 1990-10-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Effects of benazepril and metoprolol OROS alone and in combination on myocardial ischemia in patients with chronic stable angina. | |
| P478 | volume | 16 |
| Q37131815 | A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of STA-2 (Green Tea Polyphenols) in Patients with Chronic Stable Angina |
| Q77853784 | ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stab |
| Q54103047 | Acute anti-ischemic effects of perindoprilat in men with coronary artery disease and their relation with left ventricular function. |
| Q36811049 | Angiotensin converting enzyme inhibition in chronic stable angina: effects on myocardial ischaemia and comparison with nifedipine |
| Q40490655 | Angiotensin converting enzyme inhibitors in angina and myocardial infarction. What role will they play in the 1990s? |
| Q38297868 | Angiotensin converting enzyme inhibitors--do they have an anti-ischemic action? |
| Q34236623 | Angiotensin-converting enzyme inhibitors |
| Q36699417 | Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure |
| Q41682227 | Bradykinin-mediated cardiovascular protective actions of ACE inhibitors. A new dimension in anti-ischaemic therapy? |
| Q71907130 | Comparison between metoprolol orally osmotic once daily and metoprolol two or three times daily in suppressing exercise-induced and daily myocardial ischemia |
| Q35316627 | Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease |
| Q42578752 | Effects of ACE inhibitors on coronary haemodynamics and angina pectoris |
| Q54198302 | Effects of lisinopril on congestive heart failure in normotensive patients with diastolic dysfunction but intact systolic function. |
| Q32076742 | Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia |
| Q68557916 | Is there a role for angiotensin-converting enzyme inhibitors in the treatment of chronic myocardial ischemia? |
| Q61965219 | Long-Term Anti-Ischemic Effects of Angiotensin-Converting Enzyme Inhibition in Patients After Myocardial Infarction fn1fn1This study was presented in part at the 46th Annual Scientific Session of the American College of Cardiology, Anaheim, Californi |
| Q32055028 | Reduction of exercise-induced myocardial ischemia during add-on treatment with the angiotensin-converting enzyme inhibitor enalapril in patients with normal left ventricular function and optimal beta blockade. |
| Q43610510 | The Angiotensin Converting Enzyme Inhibition Post Revascularization Study (APRES). Effects of ramipril in patients with reduced left ventricular function. Rationale, design, methods, baseline characteristics and first-year experience |
| Q41292908 | The renin-angiotensin-aldosterone system and cardiac ischaemia |
Search more.